May & Baker Nigeria Plc has released its unaudited consolidated financial statements for the second quarter ended 30 June, 2021 with revenue growth to N2.82 billion from N2.243 billion in Q2 2020.
Profit for the quarter however dropped by 22.26% to N307.902 million from N396.088 million in Q2 2020.
May & Baker Nigeria Plc is involved in the manufacturing, sale and distribution of human pharmaceuticals, human vaccines and consumer products.
